Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.209.40 CHF
Change Today +6.40 / 3.15%
Volume 80.0
DESN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Berlin
As of 6:51 AM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

dottikon es holding ag-br (DESN) Snapshot

Open
SFr.204.00
Previous Close
SFr.203.00
Day High
SFr.209.40
Day Low
SFr.204.00
52 Week High
07/8/14 - SFr.234.46
52 Week Low
11/27/14 - SFr.190.00
Market Cap
266.5M
Average Volume 10 Days
35.4
EPS TTM
SFr.-1.01
Shares Outstanding
1.3M
EX-Date
09/25/14
P/E TM
--
Dividend
--
Dividend Yield
2.35%
Current Stock Chart for DOTTIKON ES HOLDING AG-BR (DESN)

Related News

No related news articles were found.

dottikon es holding ag-br (DESN) Related Businessweek News

No Related Businessweek News Found

dottikon es holding ag-br (DESN) Details

Dottikon ES Holding AG, a fine chemical company, manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for chemical and pharmaceutical industry. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetics and pharmaceuticals, as well as a performance additive in various industries. The company’s pharmaceutical products are used in drug products for the treatment of heart diseases, asthma, high blood pressure, ulcers, and cancer; and industrial chemicals are used in food additives, cosmetics, electro-chemicals, photo-chemicals, and agricultural chemicals. In addition, the company is involved in recycling and waste treatment activities. It operates in Switzerland, Northern Europe, Southern Europe, America, and Asia. The company was founded in 1913 and is based in Dottikon, Switzerland.

450 Employees
Last Reported Date: 11/28/14
Founded in 1913

dottikon es holding ag-br (DESN) Top Compensated Officers

Executive Chairman, Chief Executive Officer a...
Total Annual Compensation: SFr.340.0K
Compensation as of Fiscal Year 2013.

dottikon es holding ag-br (DESN) Key Developments

Dottikon Es Holding AG Reports Earnings Results for the Year Ended March 31, 2015

Dottikon Es Holding AG reported earnings results for the year ended March 31, 2015. The company increased its net sales in the business year 2014-2015 to CHF 96.5 million, around 7% above the previous year's CHF 89.9 million. For the business year 2014-2015, the company reported a net income of approximately CHF 1 million.

Dottikon Es Holding AG Presents at BIO-Europe Spring 2015, Mar-09-2015

Dottikon Es Holding AG Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Dottikon Es Holding AG Announces Earnings Results for the Six Months Ended September 2014

Dottikon ES Holding AD announced earnings results for the six months ended September 2014. For the period, net loss shrunk to CHF 3.2 million (USD 3.3 million/EUR 2.6 million) from a loss of CHF 4.5 million, due to an improved product mix. Loss before interest and tax (LBIT) narrowed to CHF 4.3 million from CHF 5.9 million. Sales remained almost flat at CHF 39.1 million, compared with CHF 39.2 million a year earlier. EBITDA was CHF 2.8 million compared to CHF 1.0 million a year ago. Cash flow from operating activities was CHF 17.6 million compared to CHF 7.6 million a year ago. Capital expenditures were CHF 4.8 million compared to CHF 2.9 million a year ago. Free cash flow was CHF 12.8 million compared to CHF 4.7 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DESN:SW SFr.209.40 CHF +6.40

DESN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DESN.
View Industry Companies
 

Industry Analysis

DESN

Industry Average

Valuation DESN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book 0.9x
Price/Cash Flow 19.5x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DOTTIKON ES HOLDING AG-BR, please visit www.dottikon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.